These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 26424023)

  • 1. Analysis of Neuropsychiatric Adverse Events in Patients Treated with Oseltamivir in Spontaneous Adverse Event Reports.
    Ueda N; Umetsu R; Abe J; Kato Y; Nakayama Y; Kato Z; Kinosada Y; Nakamura M
    Biol Pharm Bull; 2015; 38(10):1638-44. PubMed ID: 26424023
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Assessment of neuropsychiatric adverse events in influenza patients treated with oseltamivir: a comprehensive review.
    Toovey S; Rayner C; Prinssen E; Chu T; Donner B; Thakrar B; Dutkowski R; Hoffmann G; Breidenbach A; Lindemann L; Carey E; Boak L; Gieschke R; Sacks S; Solsky J; Small I; Reddy D
    Drug Saf; 2008; 31(12):1097-114. PubMed ID: 19026027
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Post-marketing assessment of neuropsychiatric adverse events in influenza patients treated with oseltamivir: an updated review.
    Toovey S; Prinssen EP; Rayner CR; Thakrar BT; Dutkowski R; Koerner A; Chu T; Sirzen-Zelenskaya A; Britschgi M; Bansod S; Donner B
    Adv Ther; 2012 Oct; 29(10):826-48. PubMed ID: 23054689
    [TBL] [Abstract][Full Text] [Related]  

  • 4. ABCB1 polymorphisms and neuropsychiatric adverse events in oseltamivir-treated children during influenza H1N1/09 pandemia.
    L'Huillier AG; Ing Lorenzini K; Crisinel PA; Rebsamen MC; Fluss J; Korff CM; Barbe RP; Siegrist CA; Dayer P; Posfay-Barbe KM; Desmeules JA;
    Pharmacogenomics; 2011 Oct; 12(10):1493-501. PubMed ID: 21902503
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Risk of neuropsychiatric adverse events associated with the use of oseltamivir: a nationwide population-based case-crossover study.
    Kang HR; Lee EK; Kim WJ; Shin JY
    J Antimicrob Chemother; 2019 Feb; 74(2):453-461. PubMed ID: 30418537
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Incidence of neuropsychiatric adverse events in influenza patients treated with oseltamivir or no antiviral treatment.
    Smith JR; Sacks S
    Int J Clin Pract; 2009 Apr; 63(4):596-605. PubMed ID: 19335705
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The association between oseltamivir use and adverse neuropsychiatric outcomes among TRICARE beneficiaries, ages 1 through 21 years diagnosed with influenza.
    Casscells SW; Granger E; Kress AM; Linton A
    Int J Adolesc Med Health; 2009; 21(1):79-89. PubMed ID: 19526698
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association between oseltamivir use and neuropsychiatric adverse events in influenza patients: a nationwide population-based cohort study.
    Kang HR; Jang SC; Shin JY
    Expert Opin Drug Saf; 2021 Feb; 20(2):245-253. PubMed ID: 33183123
    [No Abstract]   [Full Text] [Related]  

  • 9. Abnormal behavior during influenza in Japan during the last seven seasons: 2006-2007 to 2012-2013.
    Nakamura Y; Sugawara T; Ohkusa Y; Taniguchi K; Miyazaki C; Momoi M; Okabe N
    J Infect Chemother; 2014 Dec; 20(12):789-93. PubMed ID: 25284815
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Oseltamivir and abnormal behaviors: true or not?
    Yorifuji T; Suzuki E; Tsuda T
    Epidemiology; 2009 Jul; 20(4):619-21. PubMed ID: 19367165
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Risk of adverse events following oseltamivir treatment in influenza outpatients, Vaccine Safety Datalink Project, 2007-2010.
    Greene SK; Li L; Shay DK; Fry AM; Lee GM; Jacobsen SJ; Baxter R; Irving SA; Jackson ML; Naleway AL; Nordin JD; Narwaney KJ; Lieu TA
    Pharmacoepidemiol Drug Saf; 2013 Apr; 22(4):335-44. PubMed ID: 23129321
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The safety of oseltamivir in patients with influenza: analysis of healthcare claims data from six influenza seasons.
    Blumentals WA; Song X
    MedGenMed; 2007 Oct; 9(4):23. PubMed ID: 18311373
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neuropsychiatric adverse effects of oseltamivir in the FDA Adverse Event Reporting System, 1999-2012.
    Hoffman KB; Demakas A; Erdman CB; Dimbil M; Doraiswamy PM
    BMJ; 2013 Jul; 347():f4656. PubMed ID: 23881998
    [No Abstract]   [Full Text] [Related]  

  • 14. Neuropsychiatric events in an adult patient with influenza a (H3N2) treated with oseltamivir (Tamiflu): a case report.
    Chen R; Fang Z; Huang Y
    BMC Infect Dis; 2019 Mar; 19(1):224. PubMed ID: 30832611
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Survey of compliance with oseltamivir phosphate therapy in Japan.
    Ushijima K; Higuchi S; Fujimura A
    Am J Ther; 2009; 16(1):8-10. PubMed ID: 22573053
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Safety profile of oseltamivir during the 2009 influenza pandemic.
    Donner B; Bader-Weder S; Schwarz R; Peng MM; Smith JR; Niranjan V
    Pharmacoepidemiol Drug Saf; 2011 May; 20(5):532-43. PubMed ID: 21448900
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Oseltamivir- related psychiatric manifestations.
    Guisado-Macías JA; Rodríguez FF; Méndez-Sánchez F; Bolívar-Perálvarez M
    Actas Esp Psiquiatr; 2012; 40(1):46-8. PubMed ID: 22344496
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Oseltamivir use and severe abnormal behavior in Japanese children and adolescents with influenza: Is a self-controlled case series study applicable?
    Fukushima W; Ozasa K; Okumura A; Mori M; Hosoya M; Nakano T; Tanabe T; Yamaguchi N; Suzuki H; Mori M; Hatayama H; Ochiai H; Kondo K; Ito K; Ohfuji S; Nakamura Y; Hirota Y
    Vaccine; 2017 Aug; 35(36):4817-4824. PubMed ID: 28818475
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Relationship Between Oseltamivir and Suicide in Pediatric Patients.
    Harrington R; Adimadhyam S; Lee TA; Schumock GT; Antoon JW
    Ann Fam Med; 2018 Mar; 16(2):145-148. PubMed ID: 29531106
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Adolescent jump case in Japan associated with influenza but not oseltamivir.
    Terada K; Kawai Y; Monju A; Wakabayashi T; Ouchi K
    Pediatr Infect Dis J; 2008 Jan; 27(1):88-9. PubMed ID: 18162953
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.